Ertiprotafib
CAS: 251303-04-5
Ref. 3D-BKA30304
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Información del producto
- benzenepropanoic acid, alpha-[4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thien-4-yl)-2,6-dimethylphenoxy]-, (alphaR)-
Ertiprotafib is a natural drug that inhibits the activity of enzymes involved in the synthesis of fatty acids and proteins. Ertiprotafib has been shown to inhibit phosphatase, acetylcholinesterase, hydroxylase, and phosphodiesterase. The inhibition of these enzymes leads to an increase in messenger RNA levels and protein production by cells. This drug also has anti-cancer properties. Clinical studies have shown that Ertiprotafib improves diabetic patients’ glucose tolerance and reduces insulin resistance.
Propiedades químicas
Consulta técnica sobre: 3D-BKA30304 Ertiprotafib
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
